GGrantIndex
Sort

40,608 grants matching prostate cancer

Cellular Pharmacology of Rapamycin

$336,000
Burnham Institute For Medical Research · R01 · FY2005 · CA

Cellular Pharmacology of Rapamycin

$336,000
Burnham Institute For Medical Research · R01 · FY2004 · CA

Cellular Pharmacology of Rapamycin

$336,000
Burnham Institute For Medical Research · R01 · FY2003 · CA

Molecular mechanism of Androgen Receptor mediated transcription

$336,000
Zhao Wang · Baylor College Of Medicine · R01 · FY2024 · GM

Molecular mechanism of Androgen Receptor mediated transcription

$336,000
Zhao Wang · Baylor College Of Medicine · R01 · FY2023 · GM

Etiologic Studies of Prostate Cancer

$335,997
Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA

Characterization of WWOX, the Ca. Gene Spanning FREA16D

$335,975
University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA

Characterization of WWOX, the Ca. Gene Spanning FREA16D

$335,975
University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA

Characterization of WWOX, the Ca. Gene Spanning FREA16D

$335,975
University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA

Oncogenic Met Signaling in Urologic Malignancies

$335,956
Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Selection and Characterization of PSMA Ligands from Phage-Displayed Libraries

$335,955
Gary Fujii · Molecular Express, Inc. · R43 · FY2006 · CA

Dietary histone deactylase inhibitors in prostate cancer prevention

$335,954
Emily Ho · Oregon State University · R01 · FY2008 · CA

Generating molecular markers that selectively label urothelial sub-populations

$335,916
Cathy L Mendelsohn · Columbia University Health Sciences · U01 · FY2012 · DK

Enhancing anti-neoplastic activity of metformin in prostate cancer

$335,913
Xiaoqi Liu · University Of Kentucky · R01 · FY2019 · CA

Office of Translational Resources

$335,912
Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA

Clinical Protocol and Data Management

$335,912
Karen L Kelly · University Of California At Davis · P30 · FY2021 · CA

Insulin-like Growth Factor Axis and Insulin Resistance in PCPT

$335,858
Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA

The Development of Stat3 Inhibitors

$335,842
John S McMurray · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA

Pb-212 Peptide Receptor Targeted Prostate Cancer Therapy

$335,813
Timothy J. Hoffman · University Of Missouri-Columbia · R01 · FY2019 · CA

THERMALLY SENSITIVE DRUG DELIVERY SYSTEM FOR TUMORS

$335,808
Duke University · R01 · FY2000 · CA

The Development of Stat3 Inhibitors

$335,797
John S McMurray · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA

Animal Core

$335,790
Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2011 · CA

The function of Snf5, an epigenetic tumor suppressor

$335,750
Dana-Farber Cancer Institute · R01 · FY2005 · CA

Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis

$335,749
Xiaohong Li · University Of Toledo Health Sci Campus · R01 · FY2024 · CA

RANKL and BMPs in Prostate Cancer Induced Bone Lesions

$335,684
Jay R. Lieberman · University Of California Los Angeles · R01 · FY2006 · CA